Clinical Trial Update: A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of BL0175 Injection in postmenopausal women with HR-positive locally advanced or metastatic breast, ovarian, or endometrial cancer is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• BL0175

Snippet

Sponsor: Shanghai Best-Link Bioscience, LLC | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: RECRUITING